Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Exubera inhaled insulin endocrine data

In an 8-year extension trial, the average yearly reductions in lung function, as measured by forced expiratory volume (FEV1), were similar

Read the full 213 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE